Literature DB >> 3124736

Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods.

C B Inderlied1, L S Young, J K Yamada.   

Abstract

Various methods were used to determine the in vitro susceptibility of Mycobacterium avium complex strains isolated from patients with acquired immunodeficiency syndrome. Our results confirm the noted resistance of the M. avium complex to conventional antituberculosis agents. The procedures used were both agar dilution and broth dilution, including a commercially available radiometric system (BACTEC; Johnston Laboratories, Towson, Md.). In general, all strains were more resistant by an agar dilution procedure than by a broth dilution procedure. Radiometric data were analyzed by defining a value, termed T100, which provides a discrete MIC. The broth (radiometric) procedure is reproducible and convenient for screening antimicrobial agents for in vitro activity and assessing potential therapeutic efficacy. Nevertheless, there is no standard procedure for determining the in vitro susceptibility of the M. avium complex, and appropriate clinical correlation studies are needed to accurately assess the clinical relevance of any in vitro result.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124736      PMCID: PMC175023          DOI: 10.1128/AAC.31.11.1697

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

2.  Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.

Authors:  H C Engbaek; B Vergmann; I Baess
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

3.  Isolation of nontuberculous mycobacteria in the United States, 1980.

Authors:  R C Good; D E Snider
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

4.  Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.

Authors:  B G Yangco; E A Eikman; D A Solomon; S C Deresinski; J A Madden
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  Long-term results of medical treatment in Mycobacterium intracellulare infection.

Authors:  A K Dutt; W W Stead
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

6.  Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.

Authors:  L S Young; O G Berlin; C B Inderlied
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors:  J D Gay; D R DeYoung; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  Treatment of disease due to Mycobacterium intracellulare.

Authors:  P T Davidson; V Khanijo; M Goble; T S Moulding
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

9.  Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

Authors:  N Rastogi; C Frehel; A Ryter; H Ohayon; M Lesourd; H L David
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

10.  Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.

Authors:  W E Sanders; C Hartwig; N Schneider; R Cacciatore; H Valdez
Journal:  Tubercle       Date:  1982-09
View more
  45 in total

1.  Observing bacterial activity interferometrically.

Authors:  D Faragó Jardim; R Batista Santiago Neto; R R P Machado; F M Aarestrup; J P R F de Mendonça; B Lesche
Journal:  Eur Biophys J       Date:  2003-03-22       Impact factor: 1.733

2.  In vitro susceptibility of Mycobacterium kansasii to clarithromycin.

Authors:  J Biehle; S J Cavalieri
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 3.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex.

Authors:  S Naik; R Ruck
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors:  P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

6.  Species of environmental mycobacteria differ in their abilities to grow in human, mouse, and carp macrophages and with regard to the presence of mycobacterial virulence genes, as observed by DNA microarray hybridization.

Authors:  Melanie J Harriff; Martin Wu; Michael L Kent; Luiz E Bermudez
Journal:  Appl Environ Microbiol       Date:  2007-11-02       Impact factor: 4.792

7.  In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis.

Authors:  Y Miyakawa; P Ratnakar; A G Rao; M L Costello; O Mathieu-Costello; R I Lehrer; A Catanzaro
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.

Authors:  L E Bermudez; P Kolonoski; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  The changing pattern of nontuberculous mycobacterial disease.

Authors:  Joseph O Falkinham
Journal:  Can J Infect Dis       Date:  2003-09

10.  Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

Authors:  S H Siddiqi; L B Heifets; M H Cynamon; N M Hooper; A Laszlo; J P Libonati; P J Lindholm-Levy; N Pearson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.